Clinical Trials Logo

Filter by:
NCT ID: NCT06240845 Completed - Clinical trials for Lumbar Radiculopathy

Effect of High Versus Low-level Laser Therapy in Patients of Lumber Radiculopathy

Start date: August 1, 2023
Phase: N/A
Study type: Interventional

To Compare the effects of high-level laser therapy (HLLT) and low-level laser therapy (LLLT) on pain in patients with lumbar radiculopathy.

NCT ID: NCT06240819 Recruiting - Pain Clinical Trials

Cross Body vs Sleeper Stretch on Pain, Range of Motion and Functional Performance in Cricket Bowlers.

Start date: October 20, 2023
Phase: N/A
Study type: Interventional

The study is randomized and single-blinded. Ethical approval is taken from ethical committee of Riphah International University, Lahore. Participants who meet the inclusion criteria will be enrolled and allocated in group A & B through sealed envelope method by Non-probability Convenient random sampling technique. Subjects in Group A will receive sleeper stretch in a side lying position. Group B will receive cross-body stretch will be done in sitting position

NCT ID: NCT06239389 Completed - Beta-Thalassemia Clinical Trials

Comparison Of Efficacy And Safety Of Thalidomide Vs Hydroxyurea In Thalassemia Patients: A Single-Centre Pilot Study.

Start date: September 1, 2021
Phase: Phase 2
Study type: Interventional

The goal of this study is to compare the effectiveness and safety of two hemoglobin F inducer. This is single centered interventional pilot study is to compare the efficacy and safety parameters in beta thalassemia patients. As this is a pilot study, the investigator took a small number of patients. The Sample size was calculated by the World health organization sample size calculator. After screening 39 patients and 24 patients were eligible for enrollment in this study. The main objective was to evaluate safety of both drugs in genetic disorder like thalassemia. for safety evaluation, hematological parameters were evaluated that includes total bilirubin , indirect bilirubin, Serum Glutamate Pyruvate Transaminase, serum glutamic-oxaloacetic transaminase, urea, creatinine and lactate dehydrogenase were monitored . Moreover to evaluate the efficacy of drug, hematological parameters that includes hemoglobin, red blood cells , nucleated red blood cells , reticulocytes count, Red blood cells indices ( mean corpuscular hemoglobin, mean corpuscular volume and mean corpuscular hemoglobin concentration) , white blood cells and platelets were done. Another important parameters to evaluate the efficacy of hemoglobin F inducer is transfusion frequency. Test were done at baseline and after completion of study means after 06 months.

NCT ID: NCT06239207 Recruiting - Clinical trials for Androgenetic Alopecia

Efficacy and Safety of Exosomes Versus Platelet Rich Plasma in Patients of Androgenetic Alopecia

Start date: September 21, 2023
Phase: Phase 2
Study type: Interventional

Androgenetic alopecia is a common condition affects both genders. Patients of androgenetic alopecia following inclusion criteria will be enrolled after ethical approval and informed consent. Pre-treatment assessment will be done by Physian Global assessment, Patient global assessment and hair density by trichoscopy of areas under treatment. Patients will be categorized in 2 groups. Group A receiving exosomes 1session intradermally in scalp after nerve block and group B receiving PRP 2 sessions of PRP 1 month apart intradermally in scalp after nerve block. Patients will receive exosomes at strength of 2 to 10 billion particles/5ml with 0.1 ml/cm2. Follow up will be done after 1 month, 2 months, 3 months, 5 months and 6 months of completion of treatment to assess hair growth and reduce hair fall by Physian Global assessment (PGA), Patient global assessment (PtGA) and trichography. Clinical response will be graded as satisfactory (< 25%), good (25-50%) or excellent (> 50%) improvement. Details will be entered on predesigned proforma. Data will be entered and analyzed using SPSS 27. Means will be calculated for quantitative variables, frequencies for qualitative variables like pre- and post treatment response. Data will be stratified for role of effect modifiers

NCT ID: NCT06236152 Completed - Clinical trials for Tuberculous Lymphadenitis, Cervical

Steroids vs Placebo in Treatment of Tuberculous Lymphadenitis

Start date: July 1, 2022
Phase: N/A
Study type: Interventional

This study will be conducted as a single blinded randomized control trial. The goal of this clinical trial is to learn about the role of low dose steroids in the resolution of tuberculous lymphadenitis. The prime questions, this clinical trial aims to answer are: - Is there any role of starting low dose steroids in resolution of lymph node size along side standard anti-tubercular drugs in patients of tuberculous lymphadenitis? - Do low dose steroid therapy in addition to standard anti-TB drugs prevents or reduces the incidence of complications? Patients presenting to the out patient department of Pak Emirates Military Hospital, Rawalpindi with tuberculous lymphadenitis will be recruited in the study after a written informed consent. Initial size of two largest lymph nodes will be measured. They will be randomized into two groups, only one of which will be receiving the low dose steroids. The patients will be followed up on a monthly basis and regression in the lymph node size, if any will be measured. The two groups will be compared at the end of the trial.

NCT ID: NCT06234644 Completed - Down Syndrome Clinical Trials

Effects of Maze Activities in Down's Syndrome

Start date: December 5, 2023
Phase: N/A
Study type: Interventional

Down's Syndrome is due to the chromosomal disorder in 47 chromosomes instead of 46, socalled as Trisomy 21. The syndrome has several clinical symptoms including Cardiovascular,neurological, orthopedic, hormonal, cognitive and visual perceptual impairments. These childrenhave Developmental Delay. Children have hypermobility of joints, hypotonicity or ligamentous laxity, light to moderate obesity, due to underdeveloped respiratory and cardiovascular systemandshortstaturewhichleadtodecreaseinfunctionalambulation.Due to the low level of physical fitness, theseindividuals shows limitation in performing the functional tasks of daily living. The fundamental motor skill is Walking that facilitates the child to interact with the environment and helps indeveloping, social, motor and cognitive skills. Due to their delayed milestones and due to the irintellectual disability, environmental exposure is limited which hampers this fundamental skill.Hence it is necessary to asses the functional ambulation in these children. This is a Randomized Controlled Trial that will be conducted in Rising Sun Institute Of Special Children. 26 participants will be allocated randomly into 2 groups Group A will receive the conventional interventions of Down's Syndrome but the group B will receive the mobility training with Standardized Walking Obstacle Course (SWOC). Tool used for this research will be a Standardized Walking Obstacle Course (SWOC) (that is used to measure stability and speed during gait in terms of time, number of steps, number of stumbles and number of steps off the path for each participant) and Timed up and go test (Valid for the functional mobility assessment of the children with DS). The data will be analyzed by SPSS version 21

NCT ID: NCT06234020 Recruiting - Clinical trials for Anorectal Malformations

Frequency of Vertebrospinal Anomalies in Patients Presenting With Anorectal Malformations

Start date: January 16, 2024
Phase:
Study type: Observational [Patient Registry]

To determine the frequency of different vertebrospinal anomalies in patients with ARM

NCT ID: NCT06233669 Completed - Clinical trials for Burnout, Psychological

An Analysis of Burnout Among Surgery Residents at a Tertiary Care Hospital in Pakistan: A Prospective Cohort Study

Start date: June 1, 2023
Phase:
Study type: Observational

To determine the scores of exhaustion, depersonalization and personal achievement according to Maslach Burnout Inventory (MBI) in surgical residents.

NCT ID: NCT06232343 Completed - Children, Only Clinical Trials

Effects of Parachute Resistance Training in Young Athletes

Start date: December 1, 2023
Phase: N/A
Study type: Interventional

Muscular power may protect against cardiovascular disease independently of cardiorespiratory fitness. Resistance training is a useful training technique to boost running speed while enhancing other aspect of an athlete's physical condition. Resistance training is also consisting of weight training. Weight training emphasis on health exercise program. Improvements in muscular strength, power, running speed, kicking velocity, endurance, dynamic balance, flexibility, and general motor function have been observed in youth who have participated in resistance training between the ages of 8 to 14 years. These improvements strengthen young athletes' immunity to common sports ailments It will be Randomized Controlled trial in which convenient sampling technique will be used. Two groups will be formed in which participants will be divided by lottery method. Group A in which will be treated By Parachute resistance training and the other group will perform sprinters. Fatigue Assessment Scale and Strength 1RM tool will be used. The result after statistical analysis will either show this intervention is effective or not. Results will be analyzed on SPSS

NCT ID: NCT06232330 Completed - Clinical trials for Hemiplegic Cerebral Palsy

Effects of TOA Versus PNF Techniques on Trunk Control in Children With Hemiplegic Cerebral Palsy

Start date: December 1, 2023
Phase: N/A
Study type: Interventional

Cerebral palsy occurs in 2-2.5 per 1000 live births, seems to be the most common cause of lifelong physical disability, and has an impact on the child, caregivers, and society. The incidence of cerebral palsy continues to rise owing to the large numbers of premature and high-risk infants who survive. Task-oriented arm approaches promote intensive, meaningful, and goal-oriented training in subjects, and the voluntary functional activities of these subjects possibly reduce their motor disabilities.